Table 2.
Evolution of diagnostic techniques for infective endocarditis
| Diagnostic Technique | Introduction Period | Key Advantages | Limitations | Examples of Pathogens Detected | References |
|---|---|---|---|---|---|
| Blood Cultures | Early 1900s | Gold standard; can identify a wide range of bacteria in IE; easy to implement. | Fails in 30% of cases, especially post-antibiotics; slow to yield results (days). | Staphylococcus aureus, Streptococcus viridans | [19] |
| Serology | 1950s-1960s | Non-invasive; useful for fastidious organisms like Coxiella burnetii. | Requires specific tests for different organisms; lacks broad applicability. | Coxiella burnetii (Q fever) | [20] |
| Histopathology | 1900s (Routine use began later) | Direct visualization of valvular tissue; provides definitive diagnosis. | Invasive; requires heart valve biopsy; not always feasible. | Any organism causing valve damage (e.g., bacterial, fungal) | [21, 22] |
| Polymerase Chain Reaction (PCR) | 1980s-1990s | High sensitivity; detects DNA directly from clinical samples. | Relatively costly and limited to known pathogens with available primers. | Bartonella, Tropheryma whipplei | [23] |
| 16S rRNA Sequencing | Late 1990s | Broadens bacterial identification range; effective for rare and slow-growing bacteria. | Limited to bacterial pathogens; cannot detect viruses or fungi. | Tropheryma whipplei, Bartonella species | [24] |
| Metagenomic Next-Generation Sequencing (mNGS) | 2010s-Present | Rapid, comprehensive detection of bacteria, fungi, and viruses. | High cost, complex data interpretation, lack of standardized clinical protocols. | Broad range: bacterial, viral, fungal (including rare and fastidious organisms) | [25] |